SectorPharmaceutical
Established Date--
Listing Date20/10/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees15
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2001 Market Street, Suite 3915, Unit #15, Philadelphia, Pennsylvania 19103
Business
IntroductionContext Therapeutics Inc., was incorporated in Delaware in April 2015. The company is a clinical-stage biopharmaceutical company advancing T-cell-bridging bispecific antibodies for solid tumors. Its R&D pipeline includes CTIM-76 targeting CLDN 6, CT-95 targeting mesothelin, and CT-202 targeting Nectin-4, and these drug candidates are in or planned for Phase 1 clinical trials.
